Desjardins venture capital fund sells stake in drug developer Enobia Pharma

MONTREAL – Venture capital fund Capital regional et cooperatif Desjardins said Thursday that is has sold its stake in Enobia Pharma as part of a $1.08-billion takeover of the drug developer by Alexion Pharmaceuticals Inc.